Randomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol.
Feifei SunChenjing WangYi XuPingping LinYaozhong CaoJiahui ZhangXin LiXin JiangYao FuYu CaoPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2023)
Clinicaltrials, NCT05226013 (Registered April 2, 2022, Retrospectively registered). ChinaDrugTrials, CTR20211801(Registered July 27, 2021).